Frode Flem
Directeur/Bestuurslid bij Xellia Pharmaceuticals AS
Oorsprong van het eerstegraads netwerk van Frode Flem
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Xellia Pharmaceuticals AS
Xellia Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals AS develops, manufactures, and supplies pharmaceutical drugs. The firm engages in the filed of biotechnology, synthetic organic chemistry development, and analytical development. The company was founded in 1946 and is headquartered in Oslo, Norway.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Frode Flem via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
3I GROUP PLC | Investment Managers | Corporate Officer/Principal | |
UNILEVER PLC | Household/Personal Care | Corporate Officer/Principal | |
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Chief Executive Officer | |
CONSORT MEDICAL PLC | Pharmaceuticals: Major | Chief Executive Officer | |
TOUCHSTONE INNOVATIONS PLC | Investment Managers | Director/Board Member | |
AB SKF | Metal Fabrication | Comptroller/Controller/Auditor | |
SPECTRIS PLC | Electrical Products | Director/Board Member | |
BTG | Pharmaceuticals: Major | Director/Board Member | |
UDG HEALTHCARE PLC | Miscellaneous Commercial Services | Director/Board Member | |
Stena AB
Stena AB Marine ShippingTransportation Stena AB engages in the provision of investment and shipping services. It operates through the following segments: Ferry Operations, Offshore Drilling, Shipping, Property, and New Businesses. The Ferry Operations segment is managed by Stena Line, in Scandinavia, the United Kingdom, France, Germany, Latvia, Poland, the Netherlands and Ireland. The Offshore Drilling segment develops and constructs of drilling rigs and drillships. The Shipping segment comprises ownership and leasing of oil tankers and RoRo vessels. The Property segment relates to investments in residential properties and commercial properties. The New Businesses segment includes long term financial involvement and investment in operations outside Stena’s core operating areas and takes place through the business unit Stena Adactum. The company was founded on November 18, 1939 and is headquartered in Gothenburg, Sweden. | Marine Shipping | Director of Finance/CFO | |
Bain & Co., Inc.
Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Bain & Co., Inc. provides management consulting services. It offers advisory services to the companies on their critical issues and opportunities: strategy, marketing, organization, operations, technology and mergers and acquisitions, across all industries and geographies. The company was founded in 1973 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
ApaTech Ltd.
ApaTech Ltd. Medical SpecialtiesHealth Technology ApaTech Ltd. develops synthetic bone graft technology. It specializes in producing synthetic bone repair material. The company has developed a novel silicate substituted calcium phosphate bone graft material, Actifuse, which underpins the company's leadership in applying the science of silicon to bone graft technologies. Actifuse is the first of a new class of synthetic bone graft materials that combine osteoconductive, osteostimulatory and bioactive qualities resulting in accelerated bone growth. The company was founded in 2001 and is headquartered in Elstree, UK. | Medical Specialties | Chairman | |
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Chairman | |
Cancer Research Technology Ltd.
Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Medical Specialties | Chairman | |
Heriot-Watt University | College/University | Masters Business Admin | |
University of Technology Sydney | College/University | Masters Business Admin | |
University of Copenhagen | College/University | Graduate Degree | |
Norwegian University of Science & Technology | College/University | Graduate Degree | |
7TM A/S
7TM A/S Pharmaceuticals: MajorHealth Technology 7TM A/S performs research and development within biotechnology. It engages in clinical development of drugs focusing on obesity and gastrointestinal diseases. The company was founded by Thue Walter Schwartz, Anders Fink Vadsholt, Mette Kirstine Agger, Christian Ellebæk Elling, and Peter Moldt on January 1, 2000 and is headquartered in Hørsholm, Denmark. | Pharmaceuticals: Major | Chairman | |
BI Norwegian Business School | College/University | Undergraduate Degree Graduate Degree | |
Victor Hasselblad AB
Victor Hasselblad AB Electronics/AppliancesConsumer Durables Victor Hasselblad AB manufactures cameras and photographic equipment. It offers lens, or components; digital backs and scanners; flexColor software for image capturing and processing applications; and lenses and accessories. The company was founded by Fritz V. Hasselblad in 1941 and is headquartered in Gothenburg, Sweden. | Electronics/Appliances | Director/Board Member | |
Cancer Research UK
Cancer Research UK Miscellaneous Commercial ServicesCommercial Services Cancer Research UK provides cancer research services. It supports and undertakes research on the biology and causes of cancer and develops anti-cancer drugs. The firm also provides general information about cancer and types of treatments and funds projects that help patients cope with the side effects of cancer and its treatment. Its institute also operates an online portal CancerHelp UK that provides patient information. The company was founded in 2001 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member | |
Orkla Health AS
Orkla Health AS Medical DistributorsDistribution Services Orkla Health AS produces, markets, and distributes dietary products. Its products include vitamins, mineral supplements, sports nutrition, as well as weight reduction products. The company is headquartered in Oslo, Norway. | Medical Distributors | Corporate Officer/Principal | |
Handelshögskolan i Göteborg | College/University | Masters Business Admin | |
Sandoz GmbH
Sandoz GmbH Pharmaceuticals: MajorHealth Technology Sandoz GmbH manufactures generic pharmaceuticals and biotechnological drugs. Its products includes bio-similars, inhalers, patches, injectables, and oral solids. The company was founded in 1946 and is headquartered in Kundl, Austria. | Pharmaceuticals: Major | Chief Executive Officer | |
Hasselblad A/S
Hasselblad A/S Wholesale DistributorsDistribution Services Hasselblad A/S develops, produces, and markets photographic equipment, as well as computer, software, hardware, and other in related business. The company was founded on June 14, 1995 and is headquartered in Frederiksberg, Denmark. | Wholesale Distributors | Director/Board Member | |
Xellia Pharmaceuticals ApS
Xellia Pharmaceuticals ApS Medical/Nursing ServicesHealth Services Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Medical/Nursing Services | Chief Executive Officer Director of Finance/CFO Director/Board Member Chief Executive Officer | |
AZELIO AB (PUBL) | Electrical Products | Director of Finance/CFO | |
NC Advisory A/S | Investment Managers | Private Equity Analyst | |
Hasselblad Bron, Inc.
Hasselblad Bron, Inc. Wholesale DistributorsDistribution Services Hasselblad Bron, Inc. distributes photographic equipment. The private company is based in Union. | Wholesale Distributors | Director/Board Member | |
OneMed AB
OneMed AB Medical DistributorsDistribution Services OneMed AB distributes consumable medical products, devices, and technology in the healthcare industry. It also supplements its product range with services within purchasing, logistics, administration, information technology, support, education, product range planning, ordering procedures, as well as providing know-how on healthcare consequences and product management. Its product portfolio consists of products evercare, SELEFA, and BATIST. The firm offers Gloves; Surgical drapes, sets and gowns; Minor procedure sets; Protective apparel; Surgical masks and caps; Wound care and bandages; Paper and plastic protection; and Consumables. The company was founded in 2006 and is headquartered in Danderyd, Sweden. | Medical Distributors | Chairman | |
TROAX GROUP AB | Metal Fabrication | Director/Board Member | |
INSTALCO AB | Engineering & Construction | Director/Board Member | |
REAL FASTIGHETER AB | Real Estate Development | Director of Finance/CFO | |
SOFTOX SOLUTIONS | Miscellaneous Commercial Services | Chief Operating Officer | |
Our Future Health Uk
Our Future Health Uk Miscellaneous Commercial ServicesCommercial Services Our Future Health UK is a collaboration between the public, private, and charity sectors. Our Future Health UK is a member of the UK Health Data Research Alliance, which establishes best practices for the ethical use of UK health data for research at scale. The private company is based in Manchester, UK. The British company aims to be the largest health research program in the UK, bringing people together to develop new ways to prevent, detect, and treat diseases. The company is committed to protecting participants' confidentiality while maximizing the opportunity to help researchers tackle serious diseases. The CEO of the company is Andrew Roddam. | Miscellaneous Commercial Services | Director/Board Member | |
Vectron Biosolutions AS
Vectron Biosolutions AS BiotechnologyHealth Technology Vectron Biosolutions AS is a Norwegian company that specializes in developing protein production processes for researchers and manufacturers. The company is based in Trondheim, NO. The company's mission is to support their customers in realizing higher success rates, greater yields, and reduced cost of goods. The company offers tailor-made solutions by leveraging their proprietary expression technologies and extensive experience. and has subsidiaries in the United States. The company was founded in 2008, and Trond Erik Vee Aune has been the CEO of the company since 2008. | Biotechnology | Chairman | |
Zerion Pharma ApS
Zerion Pharma ApS Pharmaceuticals: MajorHealth Technology Zerion ApS operates as pharmaceutical development company. It also develops and improve drug products. The company was founded on January 14, 2019 and is headquartered in Birkerod, Denmark. | Pharmaceuticals: Major | Chairman | |
7tm Holding ApS | Chairman | ||
Immatics US, Inc.
Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | Biotechnology | Chairman |
Statistieken
Internationaal
Verenigd Koninkrijk | 13 |
Zweden | 12 |
Denemarken | 8 |
Verenigde Staten | 6 |
Noorwegen | 6 |
Sectoraal
Health Technology | 14 |
Consumer Services | 7 |
Commercial Services | 6 |
Distribution Services | 6 |
Finance | 5 |
Operationeel
Director/Board Member | 27 |
Chairman | 12 |
Corporate Officer/Principal | 10 |
Chief Executive Officer | 8 |
Director of Finance/CFO | 7 |
Sterkste connecties
- Beurs
- Insiders
- Frode Flem
- Bedrijfsconnecties